Functional Validation of microRNA-126-3p as a Platelet Reactivity Regulator Using Human Haematopoietic Stem Cells.

Published on Jan 2, 2019in Thrombosis and Haemostasis4.379
· DOI :10.1055/S-0038-1676802
Alix Garcia3
Estimated H-index: 3
(University of Geneva),
Sylvie Dunoyer-Geindre16
Estimated H-index: 16
(University of Geneva)
+ 3 AuthorsPierre Fontana31
Estimated H-index: 31
(Geneva College)
Background Platelets are an abundant source of micro-ribonucleic acids (miRNAs) that may play a role in the regulation of platelet function. Some miRNAs, such as miR-126-3p, have been noted as potential biomarkers of platelet reactivity and the recurrence of cardiovascular events. However, the biological relevance of these associations remains uncertain, and the functional validation of candidate miRNAs on human-derived cells is lacking. Objective This article functionally validates miR-126-3p as a regulator of platelet reactivity in platelet-like structures (PLS) derived from human haematopoietic stem cells. Materials and Methods CD34+-derived megakaryocytes were transfected with miR-126-3p and differentiated in PLS. PLS reactivity was assessed using perfusion in a fibrinogen-coated flow chamber. miR-126-3p's selected gene targets were validated using quantitative polymerase chain reaction, protein quantification and a reporter gene assay. Results CD34+-derived megakaryocytes transfected with miR-126-3p generated PLS exhibiting 156% more reactivity than the control. These functional data were in line with those obtained analysing CD62P expression. Moreover, miR-126-3p transfection was associated with the down-regulation of a disintegrin and metalloproteinase-9 (ADAM9) messenger RNA (mRNA), a validated target of miR-126-3p, and of Plexin B2 (PLXNB2) mRNA and protein, an actin dynamics regulator. Silencing PLXNB2 led to similar functional results to miR-126-3p transfection. Finally, using a reporter gene assay, we validated PLXNB2 as a direct target of miR-126-3p. Conclusion We functionally validated miR-126-3p as a regulator of platelet reactivity in PLS derived from human haematopoietic stem cells. Moreover, PLXNB2 was validated as a new gene target of miR-126-3p in human cells, suggesting that miR-126-3p mediates its effect on platelets, at least in part, through actin dynamics regulation.
📖 Papers frequently viewed together
107 Citations
61 Citations
204 Citations
Abstract Ovarian cancer is one of the leading malignancies in women and the 5-year survival rate of ovarian cancer still remains poor. In the present study, we aimed to investigate the interaction between the miR-126-3p and PLXNB2 in the progression of ovarian cancer. The qRT-PCR data revealed a reduction of miR-126-3p level in ovarian cancer tissues comparing to the adjacent normal tissues. Over-expression of miR-126-3p in ovarian cancer cells suppressed cell proliferation and invasion and the ...
25 CitationsSource
#1Nicholas P. Sunderland ('KCL': King's College London)H-Index: 2
#2Philipp Skroblin ('KCL': King's College London)H-Index: 18
Last. Manuel MayrH-Index: 81
view all 8 authors...
Over the last few years, several groups have evaluated the potential of microRNAs (miRNAs) as biomarkers for cardiometabolic disease. In this review, we discuss the emerging literature on the role of miRNAs and other small noncoding RNAs in platelets and in the circulation, and the potential use of miRNAs as biomarkers for platelet activation. Platelets are a major source of miRNAs, YRNAs, and circular RNAs. By harnessing multiomics approaches, we may gain valuable insights into their potential ...
102 CitationsSource
#1Alaina Schlinker (NU: Northwestern University)H-Index: 4
#2Mark Duncan (NU: Northwestern University)H-Index: 4
Last. William M. Miller (NU: Northwestern University)H-Index: 58
view all 5 authors...
In vitro-derived platelets (PLTs), which could provide an alternative source of PLTs for patient transfusions, are formed from polyploid megakaryocytes (MKs) that extend long cytoplasmic projections, termed proplatelets (proPLTs). In this study, we compared polyploidization and proPLT formation (PPF) of MKs cultured on surfaces that either promote or inhibit protein adsorption and subsequent cell adhesion. A megakaryoblastic cell line exhibited increased polyploidization and arrested PPF on a lo...
4 CitationsSource
#1Catherine StrasselH-Index: 16
#2Nathalie BrouardH-Index: 9
Last. François LanzaH-Index: 58
view all 10 authors...
The mechanisms regulating megakaryopoiesis and platelet production (thrombopoiesis) are still incompletely understood. Identification of a progenitor with enhanced thrombopoietic capacity would be useful to decipher these mechanisms and to improve our capacity to produce platelets in vitro. Differentiation of peripheral blood CD34+ cells in the presence of bone marrow–human mesenchymal stromal cells (MSCs) enhanced the production of proplatelet-bearing megakaryocytes (MKs) and platelet-like elem...
41 CitationsSource
#1Colin D. Eichinger (UofU: University of Utah)H-Index: 4
#2Aaron L. FogelsonH-Index: 31
Last. Vladimir HladyH-Index: 35
view all 3 authors...
A novel functional assay of antiplatelet drug efficacy was designed by utilizing the phenomena of platelet margination in flowing blood and transient platelet contacts with surface-immobilized platelet agonists. Flow margination enhances transient contacts of platelets with the walls of flow chambers covered with surface-immobilized proteins. Depending on the type and the surface density of the immobilized agonists, such transient interactions could “prime” the marginated platelet subpopulation ...
5 CitationsSource
#1Britt Van AelstH-Index: 5
#2Hendrik B. FeysH-Index: 24
Last. Veerle Compernolle (UGent: Ghent University)H-Index: 16
view all 5 authors...
Blood platelets prepared for transfusion gradually lose hemostatic function during storage. Platelet function can be investigated using a variety of (indirect) in vitro experiments, but none of these is as comprehensive as microfluidic flow chambers. In this protocol, the reconstitution of thrombocytopenic fresh blood with stored blood bank platelets is used to simulate platelet transfusion. Next, the reconstituted sample is perfused in microfluidic flow chambers which mimic hemostasis on expose...
7 CitationsSource
#1Antoine BlinH-Index: 2
#2Anne Le Goff (University of Paris)H-Index: 8
Last. Dominique Baruch (French Institute of Health and Medical Research)H-Index: 22
view all 10 authors...
Platelets are small anucleate cells that circulate in blood and are responsible for the arrest of bleeding. Platelets are formed by fragmentation of larger cells called megakaryocytes (MKs). Thrombocytopenia (insufficient platelet count) is a major condition, often requiring platelet transfusions. High collection costs, donor shortage, immunogenicity, risk of contamination and storage issues represent the main limits of this therapeutic approach. People have tried to make artificial platelets bu...
44 CitationsSource
#1Anne Zufferey (University of Geneva)H-Index: 9
#2Mark Ibberson (UNIL: University of Lausanne)H-Index: 24
Last. Pierre Fontana (University of Geneva)H-Index: 31
view all 9 authors...
Platelet reactivity (PR) is variable between individuals and modulates clinical outcome in cardiovascular (CV) patients treated with antiplatelet drugs. Although several data point to a genetic control of platelet reactivity, the genes contributing to the modulation of this phenotype are not clearly identified. Integration of data derived from high-throughput technologies may yield novel insights into the molecular mechanisms that govern platelet reactivity. The aim of this study is to identify ...
10 CitationsSource
#1Dorothee Kaudewitz ('KCL': King's College London)H-Index: 6
#2Philipp Skroblin ('KCL': King's College London)H-Index: 18
Last. Manuel Mayr ('KCL': King's College London)H-Index: 81
view all 24 authors...
Rationale: Platelets shed microRNAs (miRNAs). Plasma miRNAs change on platelet inhibition. It is unclear whether plasma miRNA levels correlate with platelet function. Objective: To link small RNAs to platelet reactivity. Methods and Results: Next-generation sequencing of small RNAs in plasma revealed 2 peaks at 22 to 23 and 32 to 33 nucleotides corresponding to miRNAs and YRNAs, respectively. Among YRNAs, predominantly, fragments of RNY4 and RNY5 were detected. Plasma miRNAs and YRNAs were measu...
107 CitationsSource
#1Jeremy Meyer (University of Geneva)H-Index: 13
#2Esma Lejmi (University of Geneva)H-Index: 3
Last. Leo Buhler (University of Geneva)H-Index: 59
view all 6 authors...
Summary Platelets are involved in the early phases of liver regeneration. Moreover, platelet transfusion and thrombocytosis were recently shown to enhance hepatocyte proliferation. However, the precise mechanisms remain elusive. This review discusses the latest updates regarding the mechanisms by which platelets stimulate liver regeneration, focusing on their interactions with liver sinusoidal endothelial cells and on their fate within the liver. Following liver injury, platelets are recruited t...
59 CitationsSource
Cited By19
#1Alix Garcia (University of Geneva)H-Index: 3
#2Sylvie Dunoyer-Geindre (University of Geneva)H-Index: 16
Last. Pierre Fontana (University of Geneva)H-Index: 31
view all 3 authors...
MicroRNAs (miRNAs) are a class of non-coding RNAs known to repress mRNA translation and subsequent protein production. miRNAs are predicted to modulate many targets and are involved in regulating various cellular processes. Identifying their role in cell function regulation may allow circulating miRNAs to be used as diagnostic or prognostic markers of various diseases. Increasing numbers of clinical studies have shown associations between circulating miRNA levels and platelet reactivity or the r...
1 CitationsSource
#2Rui Wang (WHU: Wuhan University)
Last. Hongyan Liu (WHU: Wuhan University)
view all 3 authors...
Objective. The aim of the study was to investigate molecular mechanisms underlying the role of miR-126-5p in cisplatin (DDP) sensitivity of non-small-cell lung cancer (NSCLC). Methods. The expression of miR-126-5p and ADAM9 in NSCLC cancer tissues and adjacent tissues, cisplatin-sensitive and drug-resistant NSCLC patient tissues, human normal lung epithelial cells (BESA-2B), human lung adenocarcinoma cell lines A549 and H1560, and cisplatin-resistant mutant cell lines A549/DDP and H1560/DDP was ...
#1Alix Garcia (University of Geneva)H-Index: 3
#2Sylvie Dunoyer-Geindre (University of Geneva)H-Index: 16
Last. Pierre Fontana (University of Geneva)H-Index: 31
view all 6 authors...
BACKGROUND Several platelet-derived miRNAs are associated with platelet reactivity (PR) and clinical outcome in cardiovascular patients. We previously showed an association between miR-204-5p and PR in stable cardiovascular patients, but data on functional mechanisms are lacking. AIMS To validate miR-204-5p as a regulator of PR in platelet-like structures (PLS) derived from human megakaryocytes and to address mechanistic issues. METHODS Human hematopoietic stem cells were differentiated into meg...
#1Clemens Gutmann ('KCL': King's College London)H-Index: 3
#2Abhishek Joshi ('KCL': King's College London)H-Index: 8
Last. Manuel Mayr ('KCL': King's College London)H-Index: 81
view all 4 authors...
SIGNIFICANCE Levels of platelet non-coding RNAs are altered by disease, and non-coding RNAs may exert functions inside and outside of platelets. Their role in physiologic haemostasis and pathologic thrombosis remains to be explored. Recent Advances: The number of RNA classes identified in platelets has been growing in the last decade. Apart from coding messenger RNAs, the RNA landscape in platelets comprises non-coding RNAs such as microRNAs, circular RNAs, long non-coding RNAs, YRNAs and potent...
2 CitationsSource
#1Pamela Czajka (Medical University of Warsaw)H-Index: 3
#2Alex Fitas (Medical University of Warsaw)H-Index: 2
Last. Marek Postuła (Medical University of Warsaw)H-Index: 16
view all 9 authors...
MicroRNAs (miRNAs) are small, noncoding RNAs, able to regulate cellular functions by specificgene modifications. Platelets are the major source for circulating miRNAs, with significant regulatory potential on cardiovascular pathophysiology. MiRNAs have been shown to modify the expression of platelet proteins influencing platelet reactivity. Circulating miRNAs can be determined from plasma, serum, or whole blood, and they can be used as diagnostic and prognostic biomarkers of high platelet reacti...
#1Alix Garcia (University of Geneva)H-Index: 3
#2Sylvie Dunoyer-Geindre (University of Geneva)H-Index: 16
Last. Pierre Fontana (Geneva College)H-Index: 31
view all 6 authors...
MicroRNAs (miRNAs) are small noncoding RNAs modulating protein production. They are key players in regulation of cell function and are considered as biomarkers in several diseases. The identification of the proteins they regulate, and their impact on cell physiology, may delineate their role as diagnostic or prognostic markers and identify new therapeutic strategies. During the last 3 decades, development of a large panel of techniques has given rise to multiple models dedicated to the study of ...
5 CitationsSource
#1Leilei Lin (HMU: Harbin Medical University)H-Index: 3
#2Yu Wang (HMU: Harbin Medical University)H-Index: 6
Last. Yinghua Li (HMU: Harbin Medical University)H-Index: 4
view all 13 authors...
BACKGROUND As a common haematological malignancy, acute myeloid leukaemia (AML), particularly with extramedullary infiltration (EMI), often results in a high mortality rate and poor prognosis. Circular RNAs (circRNAs) regulate biological and pathogenic processes, suggesting a potential role in AML. We have previously described the overall alterations in circRNAs and their regulatory networks between patients with AML presenting with and without EMI. This study aims to find new prognostic and the...
#1Marina L. S. Santos (FIOCRUZ: Oswaldo Cruz Foundation)H-Index: 4
#2Roney S. Coimbra (FIOCRUZ: Oswaldo Cruz Foundation)H-Index: 17
Last. Luzia H. Carvalho (FIOCRUZ: Oswaldo Cruz Foundation)H-Index: 24
view all 11 authors...
Severe thrombocytopenia can be a determinant factor in the morbidity of Plasmodium vivax, the most widespread human malaria parasite. Although immune mechanisms may drive P. vivax-induced severe thrombocytopenia (PvST), the current data on the cytokine landscape in PvST is scarce and often conflicting. Here, we hypothesized that the analysis of the bidirectional circuit of inflammatory mediators and their regulatory miRNAs would lead to a better understanding of the mechanisms underlying PvST. F...
#1Marius KellerH-Index: 3
#2Valbona MirakajH-Index: 17
Last. Peter RosenbergerH-Index: 28
view all 4 authors...
Cardiovascular pathologies are often induced by inflammation. The associated changes in the inflammatory response influence vascular endothelial biology; they complicate the extent of ischaemia and reperfusion injury, direct the migration of immune competent cells and activate platelets. The initiation and progression of inflammation is regulated by the classical paradigm through the system of cytokines and chemokines. Therapeutic approaches have previously used this knowledge to control the ext...
2 CitationsSource
#1Stefan Stojkovic (Medical University of Vienna)H-Index: 12
#2Patricia P. Wadowski (Medical University of Vienna)H-Index: 8
Last. Thomas Gremmel (Medical University of Vienna)H-Index: 21
view all 12 authors...
Background Monocyte–platelet aggregates (MPAs) are a sensitive marker of in vivo platelet activation in acute coronary syndrome (ACS) and associated with clinical outcomes. MicroRNAs (miRs) play an important role in the regulation of platelet activation, and may influence MPA formation. Both, miRs and MPA, could be influenced by the type of P2Y12 inhibitor. Aim To study the association of platelet-related miRs with MPA formation in ACS patients on dual antiplatelet therapy (DAPT), and to compare...
1 CitationsSource